Hologic (HOLX) Tops Q4 EPS by 5c; offers guidance

Hologic (NASDAQ: HOLX) reported Q4 EPS of $0.89, $0.05 better than the analyst estimate of $0.84. Revenue for the quarter came in at $945.3 million versus the consensus estimate of $940.03 million.

GUIDANCE:

Hologic sees Q1 2024 EPS of $0.92-$0.97, versus the consensus of $0.94. Hologic sees Q1 2024 revenue of $960-985 million, versus the consensus of $1017 million.

Hologic sees FY2024 EPS of $3.90-$4.10, versus the consensus of $3.90. Hologic sees FY2024 revenue of $3.92-4.02 billion, versus the consensus of $4.023 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Hologic recalls BioZorb markers after reported injuries - FDA
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank